Ciprofloxacin 750 MG

DRUG6 trials

Conditions

Acute Myelogenous LeukemiaAcute Myeloid LeukemiaBronchiectasis AdultHealthy SubjectsLeukemiaPharmacokineticsPseudomonas Aeruginosa InfectionSpontaneous Bacterial Peritonitis

Phase 1

Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101)

TerminatedNCT02773732

University of FloridaAcute Myelogenous Leukemia, Acute Myeloid Leukemia, Leukemia

Start: 2016-12-16End: 2021-11-15Updated: 2022-08-05

A Pilot Study to Evaluate the PK Profile of PrimeC-ER Tablets in Healthy Adult Subjects

CompletedNCT05232461

NeuroSense Therapeutics Ltd.Pharmacokinetics

Start: 2022-04-08End: 2022-08-30Updated: 2022-10-25

A Multiple-Dose PK Study to Evaluate the Comparative Bioavailability of PrimeC Tablets to Ciprofloxacin Tablets Co-administered With Celecoxib Capsules, in Healthy Adult Subject

CompletedNCT05436678

NeuroSense Therapeutics Ltd.Pharmacokinetics

Start: 2022-07-26End: 2022-10-20Updated: 2023-02-08

Bioequivalence Study of Ciprofloxacin in Healthy Adult Subjects Under Fasting Condition

CompletedNCT05532267

Future University in EgyptHealthy Subjects

Start: 2020-11-04End: 2020-11-13Updated: 2022-09-08

Phase 3

Rifaximin as a Prophylaxis of Spontaneous Bacterial Peritonitis in Comparison With Ciprofloxacin

CompletedNCT06234046

Ain Shams UniversitySpontaneous Bacterial Peritonitis

Start: 2023-05-28End: 2023-12-15Updated: 2024-01-31

Phase 4

Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis

RecruitingNCT06093191

Shanghai Pulmonary Hospital, Shanghai, ChinaBronchiectasis Adult, Pseudomonas Aeruginosa Infection

Start: 2023-09-25End: 2025-12-30Target: 364Updated: 2024-12-18

Related Papers

A phase ib clinical trial of oral ciprofloxacin and etoposide in subjects with resistant acute myeloid leukemia

Leukemia & lymphoma/Leukemia and lymphoma2024-06-062 citations

A phase 4 multicentre, 2×2 factorial randomised, double-blind, placebo-controlled trial to investigate the efficacy and safety of tobramycin inhalation solution for<i>Pseudomonas aeruginosa</i>eradication in bronchiectasis: ERASE